Phase 1 Breast Cancer (Locally Advanced or Metastatic) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC)

HER2-positive Breast CancerBreast Cancer (Locally Advanced or Metastatic)

Beijing Biotech60 enrolled1 locationNCT07486089

Recruiting

Phase 1Phase 2

EBNK-001 Allogeneic NK Cells With Low-Dose IL-15 ± Pembrolizumab in Advanced Solid Tumors

SarcomaCancerLeukaemia+2 more

Essen Biotech83 enrolled1 locationNCT07410676

Recruiting

Phase 1

A Study of SH009 Injection in Patients With Advanced Solid Tumors.

Esophageal CancerBreast Cancer (Locally Advanced or Metastatic)Lung Cancer (NSCLC)+4 more

Nanjing Sanhome Pharmaceutical, Co., Ltd.150 enrolled1 locationNCT07390838